ATEC’s Strong Surgeon Adoption Trends Drive Guidance Raise
The company grew 25% in the second quarter of 2024, taking people and market share from spine's incumbent players....
The company grew 25% in the second quarter of 2024, taking people and market share from spine's incumbent players....
The company's MACI sales grew over 20% in the second quarter of 2024 as biopsy rates and conversions ramp up...
The acquisition includes OrthoGrid's fluoroscopy-based Hip AI surgical assistance platform, as well as two additional FDA-cleared orthopedic applications....
Pangea is indicated for internal fixation and stabilization of bone fractures, osteotomies and arthrodesis in normal and osteopenic bone....
Funds will support commercial growth, clinical education and product development enhancements for the OptiMesh implant portfolio....
The company's orthopedic sale grew in the mid single digits during the second quarter as its transformation plan shows results....
The company's sales declined in the low single digits in the second quarter of 2024 amid a bevy of ongoing...
In part, proceeds will support product line extensions, launches and smart sensor implant delivery R&D, as well as entrance to...
The company marked 4,000 surgical cases worldwide and 1,000 cases in the U.S. with its SuperBall Meniscal Repair System....
The dual-use robotics and standalone navigation platform will become part of the VELYS Enabling Technologies Portfolio and integrate with the...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.